T. Rowe Price Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105M | Sell |
|
|||||
|
2025
Q1 | $158M | Sell |
|
|||||
|
2024
Q4 | $296M | Buy |
|
|||||
|
2024
Q3 | $371M | Sell |
|
|||||
|
2024
Q2 | $466M | Buy |
|
|||||
|
2024
Q1 | $343M | Buy |
|
|||||
|
2023
Q4 | $390M | Buy |
|
|||||
|
2023
Q3 | $299M | Buy |
|
|||||
|
2023
Q2 | $321M | Sell |
|
|||||
|
2023
Q1 | $581M | Buy |
|
|||||
|
2022
Q4 | $387M | Sell |
|
|||||
|
2022
Q3 | $410M | Buy |
|
|||||
|
2022
Q2 | $210M | Sell |
|
|||||
|
2022
Q1 | $227M | Sell |
|
|||||
|
2021
Q4 | $271M | Sell |
|
|||||
|
2021
Q3 | $505M | Buy |
|
|||||
|
2021
Q2 | $558M | Sell |
|
|||||
|
2021
Q1 | $497M | Buy |
|
|||||
|
2020
Q4 | $413M | Buy |
|
|||||
|
2020
Q3 | $389M | Buy |
|
|||||
|
2020
Q2 | $323M | Sell |
|
|||||
|
2020
Q1 | $1.36B | Buy |
|
|||||
|
2019
Q4 | $597M | Buy |
|
|||||
|
2019
Q3 | $257M | Buy |
|
|||||
|
2019
Q2 | $257M | Buy |
|
|||||
|
2019
Q1 | $249M | Sell |
|
|||||
|
2018
Q4 | $386M | Sell |
|
|||||
|
2018
Q3 | $630M | Sell |
|
|||||
|
2018
Q2 | $573M | Sell |
|
|||||
|
2018
Q1 | $1.1B | Sell |
|
|||||
|
2017
Q4 | $2.72B | Sell |
|
|||||
|
2017
Q3 | $3.34B | Buy |
|
|||||
|
2017
Q2 | $2.43B | Buy |
|
|||||
|
2017
Q1 | $2.22B | Sell |
|
|||||
|
2016
Q4 | $2.47B | Buy |
|
|||||
|
2016
Q3 | $2.38B | Buy |
|
|||||
|
2016
Q2 | $1.54B | Sell |
|
|||||
|
2016
Q1 | $2.11B | Buy |
|
|||||
|
2015
Q4 | $1.95B | Buy |
|
|||||
|
2015
Q3 | $1.76B | Sell |
|
|||||
|
2015
Q2 | $4.23B | Sell |
|
|||||
|
2015
Q1 | $4.56B | Sell |
|
|||||
|
2014
Q4 | $4.13B | Sell |
|
|||||
|
2014
Q3 | $4.23B | Buy |
|
|||||
|
2014
Q2 | $3.85B | Buy |
|
|||||
|
2014
Q1 | $3.72B | Buy |
|
|||||
|
2013
Q4 | $3.26B | Buy |
|
|||||
|
2013
Q3 | $2.61B | Sell |
|
|||||
|
2013
Q2 | $2.36B | Buy |
|